secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLARIVATE PLC (CLVT)
CIK:        0001764046
Form:       8-K
Filed at:   2026-07-06T21:00:42+00:00
Accession:  0000950103-26-010269
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clarivate sells Life Sciences & Healthcare business to Altaris for $600M
------------------------------------------------------------------------

- Purchase price $600M: $500M cash at close, $25M deferred, $75M senior note.
- Transaction expected to close by end of 2026; no shareholder vote required.
- Buyer's termination fee of $33M guaranteed by Altaris funds.
- Henry Levy, President of the business, gets retention agreement: RSU vesting, PSU cancellation, severance if terminated without cause within 6 months post-close.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/0000950103-26-010269-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1764046/000095010326010269/dp249688_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-26-010269

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer